The Efficacy and Safety of Nanoparticle-Based Clobetasol Propionate in Managing the Inflammation and Pain in Post-Operative Cataract Patients: A Systematic Review and Meta-Analysis.

Clin Ophthalmol · 2026 · PMC13051263 · PMID 41948108

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a marginal trendno p-value reported

The safety profile of CP showed a marginal trend toward fewer adverse events compared to placebo, but without statistical significance (RR = 0.50, 95% CI [0.24, 1.04], p = 0.06).

also in 626 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.